Literature DB >> 24777190

Isolated orbital relapse of multiple myeloma in a patient with severe chronic GVHD after allogeneic hematopoietic SCT.

C Blecha1, D Wolff2, O Kölbl3, E Huber4, H Helbig1, B Holler2, E Holler2, T Dietrich-Ntoukas1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24777190     DOI： 10.1038/bmt.2014.81

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Ophthalmic manifestations of multiple myeloma.

Authors:  Shirley Fung; Dinesh Selva; Igal Leibovitch; James Hsuan; John Crompton
Journal:  Ophthalmologica       Date:  2005 Jan-Feb       Impact factor: 3.250

2.  Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.

Authors:  Luisa Giaccone; Barry Storer; Francesca Patriarca; Marcello Rotta; Roberto Sorasio; Bernardino Allione; Fabrizio Carnevale-Schianca; Moreno Festuccia; Lucia Brunello; Paola Omedè; Sara Bringhen; Massimo Aglietta; Alessandro Levis; Nicola Mordini; Andrea Gallamini; Renato Fanin; Massimo Massaia; Antonio Palumbo; Giovannino Ciccone; Rainer Storb; Ted A Gooley; Mario Boccadoro; Benedetto Bruno
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

3.  The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.

Authors:  Daniel Wolff; Hartmut Bertz; Hildegard Greinix; Anita Lawitschka; Jörg Halter; Ernst Holler
Journal:  Dtsch Arztebl Int       Date:  2011-10-28       Impact factor: 5.594

Review 4.  Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect.

Authors:  R Le Blanc; S Montminy-Métivier; R Bélanger; L Busque; D Fish; D C Roy; J Kassis; J Boileau; R Lavallée; D Bélanger; F Letendre; J Hébert; G Sauvageau; C Perreault; J Roy
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483

5.  Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.

Authors:  Benedetto Bruno; Roberto Sorasio; Francesca Patriarca; Vittorio Montefusco; Stefano Guidi; Alessandro Busca; Rosanna Scimé; Giuseppe Console; Giuseppe Milone; Giuseppe Marotta; Alida Dominietto; Luisa Giaccone; Marcello Rotta; Michele Falda; Andrea Bacigalupo; Alberto Bosi; Paolo Corradini; Renato Fanin; Simona Pollichieni; Mario Boccadoro
Journal:  Eur J Haematol       Date:  2007-02-27       Impact factor: 2.997

6.  Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.

Authors:  R Zeiser; B Deschler; H Bertz; J Finke; M Engelhardt
Journal:  Bone Marrow Transplant       Date:  2004-12       Impact factor: 5.483

Review 7.  Characteristics of orbital multiple myeloma: a case report and literature review.

Authors:  Cat N Burkat; Jeremy J Van Buren; Mark J Lucarelli
Journal:  Surv Ophthalmol       Date:  2009-08-25       Impact factor: 6.048

8.  Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas.

Authors:  A Zomas; K Stefanoudaki; M Fisfis; T Papadaki; J Mehta
Journal:  Bone Marrow Transplant       Date:  1998-06       Impact factor: 5.483
  8 in total
  1 in total

1.  Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.

Authors:  Hua Jin; Zhiping Fan; Fen Huang; Yanyan Chai; Li Xuan; Ren Lin; Na Xu; Jieyu Ye; Jing Sun; Qifa Liu
Journal:  Infection       Date:  2019-02-07       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.